Merus N.V. - ADR Peer Comparison

$90.00

$0.00 (0.00%)

As on 02-Jan-2026 09:30EDT

Market cap

$6,826 Mln

Revenue (TTM)

$51 Mln

P/E Ratio

--

P/B Ratio

8.8

Div. Yield

0 %

Edit

	Merus N.V. - ADR	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	CureVac NV (CVAC)
Market cap ($ Mln)	6,826	9,272	2,480	3,380	1,049
Revenue ($ Mln)	51	2,100	--	19	511
Net Profit ($ Mln)	-334.90	409.32	-171.57	-252.21	193.64
Net Margin (%)	-654.43	19.49	--	-1,350.73	37.93
RoE (%)	-53.25	11.47	-59.98	-96.46	25.51
Price to Earnings	--	22.68	--	--	6.96
Price-To-Book	8.81	2.74	7.40	10.60	1.03

Cashflow
Ratios

Cashflow ($ Mln)

	Merus N.V. - ADR	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	CureVac NV (CVAC)
Cash From Operating Activities	-185.84	673.55	-120.13	-182.73	101.85
Cash Flow from Investing Activities	-220.22	-249.23	-0.54	162.97	-18.44
Cash from Financing Activities	494.01	-422.90	2.68	-59.49	-5.11
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Merus N.V. - ADR	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	CureVac NV (CVAC)
ROCE (%)	-40.50	1.57	-41.11	-118.19	25.06
ROE (%)	-53.25	2.27	-41.18	-238.46	25.51
ROA (%)	-29.28	1.42	-38.90	-34.51	16.67
EBIT Margin (%)	-636.76	--	--	--	-21.69
Net Margin (%)	-654.43	4.23	--	-883.35	37.93
Cash Profit Margin (%)	0.00	--	--	--	0.00

Growth Ratios

	Merus N.V. - ADR	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	CureVac NV (CVAC)
Revenue Growth (%)	55.90	0.01	--	0.71	-6.03
EBIT Growth (%)	-54.14	--	--	--	-148.12
Net Profit Growth (%)	-50.28	-75.51	-33.06	22.34	78.81
EPS Growth (%)	-31.75	-0.75	-0.28	0.24	78.23
Book Value Growth (%)	-15.15	--	--	--	19.76

Valuation Ratios

	Merus N.V. - ADR	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	CureVac NV (CVAC)
Price / Earnings	-13.92	116.14	-7.77	-3.60	4.72
Price / Book Value	4.47	2.72	3.89	-127.74	1.10
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-9.10	27.60	-5.24	-3.49	1.52
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Merus N.V. - ADR	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	CureVac NV (CVAC)
Debt to Equity	0.00	0.45	0.00	-9.78	0.00
Short term debt to equity ratio	0.00	0.02	0.00	-0.53	0.00
Current Ratio	7.97	3.61	12.60	9.74	3.70
Quick Ratio	7.97	3.09	27.27	9.74	3.69
Interest Coverage	-8.53	3.76	-4,977.62	-2.72	27.08

Operating Efficiency Ratios

	Merus N.V. - ADR	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	CureVac NV (CVAC)
Debtors to sales (%)	37.93	23.20	--	21.69	3.84
Asset Turnover	0.04	0.34	0.00	0.04	0.44
Receivable days	45.51	89.98	--	67.84	24.71
Inventory Days	0.00	122.42	2,694.23	119.82	43.73
Payable days	73.03	30.25	6,434.88	137.64	112.69
Cash Conversion Cycle	-27.52	182.15	--	50.01	-44.25

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly